Literature DB >> 4027484

Solubilization and characterization of high and low affinity pirenzepine binding sites from rat cerebral cortex.

C P Berrie, N J Birdsall, E C Hulme, M Keen, J M Stockton.   

Abstract

An apparently monomeric form of the digitonin-solubilized muscarinic acetylcholine receptor from the rat cerebral cortex retains a high affinity of 7 X 10(7) M-1 for pirenzepine. Muscarinic receptor binding sites in the rat cerebral cortex with a low affinity for pirenzepine are solubilized with relatively little change in affinity. The ability of pirenzepine to distinguish between subtypes of muscarinic binding site in the cerebral cortex is manifest in both the membrane-bound and soluble state.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027484      PMCID: PMC1916521          DOI: 10.1111/j.1476-5381.1985.tb10566.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse.

Authors:  M P Caulfield; G A Higgins; D W Straughan
Journal:  J Pharm Pharmacol       Date:  1983-02       Impact factor: 3.765

2.  Antagonist discrimination between ganglionic and ileal muscarinic receptors.

Authors:  D A Brown; A Forward; S Marsh
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

3.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.

Authors:  R Hammer; A Giachetti
Journal:  Life Sci       Date:  1982-12-27       Impact factor: 5.037

4.  [3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex.

Authors:  M Watson; W R Roeske; H I Yamamura
Journal:  Life Sci       Date:  1982-11-01       Impact factor: 5.037

5.  Subclasses of muscarinic receptors and pirenzepine. Further experimental evidence.

Authors:  R Hammer
Journal:  Scand J Gastroenterol Suppl       Date:  1982

6.  The binding of agonists to brain muscarinic receptors.

Authors:  N J Birdsall; A S Burgen; E C Hulme
Journal:  Mol Pharmacol       Date:  1978-09       Impact factor: 4.436

7.  Two populations of binding sites for muscarinic antagonists in the rat heart.

Authors:  E C Hulme; C P Berrie; N J Birdsall; A S Burgen
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

8.  A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.

Authors:  M Watson; H I Yamamura; W R Roeske
Journal:  Life Sci       Date:  1983-06-27       Impact factor: 5.037

9.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

10.  Solubilization and characterization of guanine nucleotide-sensitive muscarinic agonist binding sites from rat myocardium.

Authors:  C P Berrie; N J Birdsall; E C Hulme; M Keen; J M Stockton
Journal:  Br J Pharmacol       Date:  1984-08       Impact factor: 8.739

View more
  5 in total

1.  Modulation of the structure-binding relationships of antagonists for muscarinic acetylcholine receptor subtypes.

Authors:  E K Pedder; P Eveleigh; D Poyner; E C Hulme; N J Birdsall
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

2.  Acetylcholine.

Authors:  David A Brown
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Characterization of agonist and antagonist binding to muscarinic cholinergic receptors solubilized from rat cerebral cortex.

Authors:  A Adem; M Sabbagh; A Nordberg
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  Pharmacological characterization of the physostigmine stimulus in rats.

Authors:  M Jung; A Perio; P Worms; P Soubrie
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  The binding of pirenzepine to digitonin-solubilized muscarinic acetylcholine receptors from the rat myocardium.

Authors:  N J Birdsall; E C Hulme; M Keen
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.